Synonyms: Anti-ASGP antibody produced in rabbit; Anti-Ascites sialoglycoprotein antibody produced in rabbit; Anti-Mucin-4 precursor antibody produced in rabbit; Anti-Pancreatic adenocarcinoma mucin antibody produced in rabbit; Anti-Testis mucin antibody produced in rabbit; Anti-Tracheobronchial mucin antibody produced in rabbit
Storage: -20C
Application: All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.
Biochem Physiol Actions: Mucin 4 (MUC 4) is a mucin protein encoded by the MUC4 gene in humans. It is referred as ASGP, MUC-4 and HSA276359. It is a transmembrane glycoprotein that is expressed in pancreatic ductal adenocarcinoma (PDAC). It has a role in pancreatic tumor progression and metastasis. It plays an important role in epithelial cell proliferation and differentiation. Its overexpression is associated with invasive tumor proliferation and several cancers. It possesses tumor-promoter functions. It is a high molecular weight membrane-bound transmembrane glycoprotein that is frequently detected in invasive and metastatic cancer. It is found to play a critical role in regulating EMT by modulating ß-catenin. This gene may function as a prognostic biomarker and could be a potential therapeutic target for lung adenocarcinoma metastasis.
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC